Mata Cases M, Casas Rodríguez J, Amat Rico J, Avila Ribera F, López Muñoz M A, Rovira Fontanals A
CAP La Mina, Sant Adrià del Besòs, Barcelona.
Aten Primaria. 1991 Dec;8(11):947-52.
An evaluation study has been done on the quality of long-term drugs prescription. The aim was to check the effectiveness of certain corrective measures agreed by the professionals working in a primary care centre. Using the results of a first evaluation made in 1989, a series of recommendations were made to reduce the prescription of drugs with a low intrinsic value (LIV). A further evaluation took place 9 months later. A relative reduction of 20.2% in LIV drugs was obtained. This represented a reduction from 25% to 20.8% of the total number of prescriptions. In the relevant pharmacological subgroups a reduction of 77.9% in the prescription of nitrites linked to barbiturites was obtained; of 60% in LIV antacids; of 50.3% in antivaricose drugs; of 36.1% in LIV laxatives; and of 30.1% in Dipiridamol. There was no improvement in the prescription of external LIVs nor cerebral vasodilators. It is concluded that the intervention has proved its usefulness in the improvement of long-term drugs prescription.
一项关于长期药物处方质量的评估研究已经完成。目的是检验在初级保健中心工作的专业人员商定的某些纠正措施的有效性。利用1989年首次评估的结果，提出了一系列建议以减少低内在价值（LIV）药物的处方。9个月后进行了进一步评估。LIV药物相对减少了20.2%。这意味着在处方总数中从25%降至20.8%。在相关的药理学亚组中，与巴比妥类药物相关的亚硝酸盐处方减少了77.9%；LIV抗酸剂减少了60%；抗静脉曲张药物减少了50.3%；LIV泻药减少了36.1%；双嘧达莫减少了30.1%。外用LIV药物和脑血管扩张剂的处方没有改善。得出的结论是，该干预措施已证明其在改善长期药物处方方面的有用性。
